38 related articles for article (PubMed ID: 31690145)
1. Mode of spread in the early phase of lymphatic metastasis in pancreatic ductal adenocarcinoma: prognostic significance of nodal microinvolvement.
Bogoevski D; Yekebas EF; Schurr P; Kaifi JT; Kutup A; Erbersdobler A; Pantel K; Izbicki JR
Ann Surg; 2004 Dec; 240(6):993-1000; discussion 1000-1. PubMed ID: 15570205
[TBL] [Abstract][Full Text] [Related]
2. Lymph node examination and survival in resected pancreatic ductal adenocarcinoma: retrospective study.
Goess R; Jäger C; Perinel J; Pergolini I; Demir E; Safak O; Scheufele F; Schorn S; Muckenhuber A; Adham M; Novotny A; Ceyhan GO; Friess H; Demir IE
BJS Open; 2024 Jan; 8(1):. PubMed ID: 38271272
[TBL] [Abstract][Full Text] [Related]
3. Dual-energy computed tomography in a multiparametric regression model for diagnosing lymph node metastases in pancreatic ductal adenocarcinoma.
Li S; Jiang D; Jiang L; Yan S; Liu L; Ruan G; Zhou X; Zhuo S
Cancer Imaging; 2024 Mar; 24(1):38. PubMed ID: 38504330
[TBL] [Abstract][Full Text] [Related]
4. Predictive role of radiomics features extracted from preoperative cross-sectional imaging of pancreatic ductal adenocarcinoma in detecting lymph node metastasis: a systemic review and meta-analysis.
Mirza-Aghazadeh-Attari M; Madani SP; Shahbazian H; Ansari G; Mohseni A; Borhani A; Afyouni S; Kamel IR
Abdom Radiol (NY); 2023 Aug; 48(8):2570-2584. PubMed ID: 37202642
[TBL] [Abstract][Full Text] [Related]
5. Initial Metastatic Site as a Prognostic Factor in Patients With Stage IV Pancreatic Ductal Adenocarcinoma.
Kim HW; Lee JC; Paik KH; Lee YS; Hwang JH; Kim J
Medicine (Baltimore); 2015 Jun; 94(25):e1012. PubMed ID: 26107667
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of ımmunhistochemical axl expression in pancreas ductal adenocarcinomas.
Oz O; Argon A; Kebat TA; Ozdemir O; Yakan S
Indian J Pathol Microbiol; 2023; 66(3):533-539. PubMed ID: 37530334
[TBL] [Abstract][Full Text] [Related]
7. Artificial Intelligence Outperforms Radiologists for Pancreatic Cancer Lymph Node Metastasis Prediction at CT.
Chu LC; Fishman EK
Radiology; 2023 Jan; 306(1):170-171. PubMed ID: 36066370
[No Abstract] [Full Text] [Related]
8. The Site of Lymph Node Metastasis: A Significant Prognostic Factor in Pancreatic Ductal Adenocarcinoma.
Aysal A; Agalar C; Cagaptay S; Safak T; Egeli T; Ozbilgin M; Unek T; Unek T; Sagol O
Turk Patoloji Derg; 2022; 38(3):284-291. PubMed ID: 35872618
[TBL] [Abstract][Full Text] [Related]
9. Nationwide Validation of the 8th American Joint Committee on Cancer TNM Staging System and Five Proposed Modifications for Resected Pancreatic Cancer.
Schouten TJ; Daamen LA; Dorland G; van Roessel SR; Groot VP; Besselink MG; Bonsing BA; Bosscha K; Brosens LAA; Busch OR; van Dam RM; Fariña Sarasqueta A; Festen S; Groot Koerkamp B; van der Harst E; de Hingh IHJT; Intven M; Kazemier G; de Meijer VE; Nieuwenhuijs VB; Raicu GM; Roos D; Schreinemakers JMJ; Stommel MWJ; van Velthuysen MF; Verdonk RC; Verheij J; Verkooijen HM; van Santvoort HC; Molenaar IQ;
Ann Surg Oncol; 2022 Sep; 29(9):5988-5999. PubMed ID: 35469113
[TBL] [Abstract][Full Text] [Related]
10. Rethinking the TNM Classification Regarding Direct Lymph Node Invasion in Pancreatic Ductal Adenocarcinoma.
Speichinger F; Dragomir MP; Schallenberg S; Loch FN; Degro CE; Baukloh AK; Hartmann L; Pozios I; Schineis C; Margonis GA; Lauscher JC; Beyer K; Kamphues C
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008365
[TBL] [Abstract][Full Text] [Related]
11. Metastatic lymph node ratio as an important prognostic factor in pancreatic ductal adenocarcinoma.
Robinson SM; Rahman A; Haugk B; French JJ; Manas DM; Jaques BC; Charnley RM; White SA
Eur J Surg Oncol; 2012 Apr; 38(4):333-9. PubMed ID: 22317758
[TBL] [Abstract][Full Text] [Related]
12. A MicroRNA Signature Identifies Pancreatic Ductal Adenocarcinoma Patients at Risk for Lymph Node Metastases.
Nishiwada S; Sho M; Banwait JK; Yamamura K; Akahori T; Nakamura K; Baba H; Goel A
Gastroenterology; 2020 Aug; 159(2):562-574. PubMed ID: 32376411
[TBL] [Abstract][Full Text] [Related]
13. The prognostic impact of para-aortic lymph node metastasis in pancreatic cancer: A systematic review and meta-analysis.
Paiella S; Sandini M; Gianotti L; Butturini G; Salvia R; Bassi C
Eur J Surg Oncol; 2016 May; 42(5):616-24. PubMed ID: 26916137
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of cancer stem cell marker CD133 expression in pancreatic ductal adenocarcinoma (PDAC): a systematic review and meta-analysis.
Li X; Zhao H; Gu J; Zheng L
Int J Clin Exp Pathol; 2015; 8(10):12084-92. PubMed ID: 26722393
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Implication of pN Stage Subdivision Using Metastatic Lymph Node Ratio in Resected Pancreatic Ductal Adenocarcinoma.
Pyo JS; Kim NY; Son BK; Chung KH
Int J Surg Pathol; 2020 May; 28(3):245-251. PubMed ID: 31690145
[TBL] [Abstract][Full Text] [Related]
16. Metastatic Lymph Node Ratio (mLNR) is a Useful Parameter in the Prognosis of Colorectal Cancer; A Meta-Analysis for the Prognostic Role of mLNR.
Pyo JS; Kim JH; Lee SY; Baek TH; Kang DW
Medicina (Kaunas); 2019 Oct; 55(10):. PubMed ID: 31590275
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
